Hepatitis B, Chronic  >>  tenofovir disoproxil fumarate  >>  Phase 4
Welcome,         Profile    Billing    Logout  

12 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tenofovir disoproxil fumarate / Generic mfg.
ACLF, NCT01074645: Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure

Completed
4
27
RoW
Tenofovir disoproxil fumarate (TDF)
Govind Ballabh Pant Hospital
Acute on Chronic Liver Failure, Hepatitis B
06/09
10/09
NCT00736190: A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection

Completed
4
90
US
Tenofovir disoproxil fumarate, Viread
Gilead Sciences
Chronic Hepatitis B
07/10
07/10
NCT00651209 / 2007-004845-14: A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)

Completed
4
105
Europe, RoW
Tenofovir, Sebivo, Tyzeka, Viread
Novartis Pharmaceuticals
Hepatitis B, Chronic
12/11
 
NCT01277601 / 2010-024586-45: Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

Completed
4
751
US, Canada, Europe, RoW
TDF, Viread®, Peg-IFN, Pegasys®
Gilead Sciences
Chronic Hepatitis B
08/14
07/15
NCT01711567: Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir

Completed
4
60
RoW
tenofovir, tenofovir (viread), entecavir, entecavir(baraclude) 0.5 mg qd
Korea University, Gilead Sciences
Chronic Hepatitis B
12/15
11/16
NCT01379508 / 2007-000180-13: Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Completed
4
241
Europe, RoW
telbivudine, LDT600, tenofovir disoproxil fumarate
Novartis Pharmaceuticals
Chronic Hepatitis B
12/15
12/15
NCT01732367: TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA

Completed
4
171
RoW
Lamivudine plus adefovir, Zeffix, Hepsera, Tenofovir, Viread
Keimyung University Dongsan Medical Center, Kyungpook National University Hospital, Daegu Catholic University Medical Center, DongGuk University, Pusan National University Hospital, Yeungnam University Hospital
Chronic Hepatitis B
03/16
04/16
FINITE CHB, NCT01320943 / 2010-021925-12: Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Completed
4
43
Europe
TDF, Viread®, Stop TDF
Gilead Sciences
Chronic Hepatitis B
07/16
08/16
IN-US-0205, NCT01639066: Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B

Completed
4
102
RoW
Tenofovir, Viread, Entecavir, Baraclude
Asan Medical Center, Samsung Medical Center, Konkuk University Medical Center, Korea University Guro Hospital, Seoul National University Hospital
Chronic Viral Hepatitis B Without Delta-agent
09/17
09/17
NCT02479880 / 2014-004939-39: Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection

Terminated
4
30
Europe
Tenofovir DF, Viread®, DEXA Scan
Gilead Sciences
Hepatitis B
02/18
04/18
IN-US-0202, NCT01639092: Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B

Completed
4
88
RoW
Tenofovir, Viread, Entecavir, Baraclude
Asan Medical Center, Samsung Medical Center, Konkuk University Medical Center, Korea University Guro Hospital, Seoul National University Hospital
Chronic Viral Hepatitis B Without Delta-agent
03/18
03/18
EMRP36100N, NCT01522625: Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Completed
4
160
RoW
tenofovir disoproxil fumarate 300mg per day, Viread® (Gilead Sciences Inc), Placebo
E-DA Hospital, Gilead Sciences, Taipei Institute of Pathology
Chronic Hepatitis B
11/18
12/18

Download Options